Welcome to our dedicated page for Gohealth SEC filings (Ticker: GOCO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking how GoHealth (GOCO) navigates changing Medicare rules means wading through hundreds of pages of SEC disclosures. Finding policy-persistency metrics in a 10-K or spotting when executives unload shares via Form 4 can feel impossible.
Stock Titan’s AI solves that problem in seconds. Our platform streams every filing to your dashboard the instant it hits EDGAR, then delivers plain-English summaries that translate actuarial jargon and CMS references into clear business drivers. Whether you need GoHealth insider trading Form 4 transactions, a quick read-through of the GoHealth annual report 10-K simplified, or an alert on the latest GoHealth 8-K material events explained, everything is here—already tagged, indexed, and searchable.
Investors typically dig into three core areas:
- Customer economics: Our AI highlights acquisition cost trends buried deep in the quarterly earnings report 10-Q filing.
- Regulatory risk: Material event 8-Ks flag CMS policy shifts practically in real time, so you can act before the market digests them.
- Management signals: Follow GoHealth executive stock transactions Form 4 and board-level compensation details in the proxy statement without combing through appendices.
Stop scrolling endless PDFs. Stock Titan provides comprehensive coverage—Form S-8s, 424Bs, even the niche N-CSR—plus AI-powered cross-links that answer natural-language questions like “understanding GoHealth SEC documents with AI” or “GoHealth earnings report filing analysis.” Make informed decisions faster with expert context and real-time data.
GoHealth, Inc. has filed a shelf registration statement covering the resale of up to 4,766,219 shares of its Class A common stock by a group of lending institutions that received the shares in a private placement. The company is not selling any shares in this offering and will not receive proceeds from sales made by these selling stockholders, who will bear any underwriting discounts and commissions.
The registered shares were issued as consideration for lenders entering into an amendment to GoHealth’s existing credit agreement and a new superpriority senior secured “priming” credit facility, which also coincided with board changes and the creation of a Transformation Committee focused on strategic alternatives. As context, GoHealth had 16,093,116 shares of Class A common stock outstanding as of November 13, 2025, and its Class A stock trades on Nasdaq under the symbol “GOCO”.
GoHealth, Inc. reported a sharp downturn for the quarter ended September 30, 2025. Net revenues were $34,186 thousand, and the company recorded a net loss of $313,918 thousand, driven by $206,163 thousand in impairment charges on indefinite and long‑lived assets. Operating expenses climbed to $322,103 thousand, resulting in a loss from operations of $287,917 thousand.
Liquidity and leverage were central themes. GoHealth amended its credit facilities and entered a Superpriority Senior Secured Credit Agreement totaling $115.0 million (including $80.0 million new‑money and $35.0 million roll‑up term loans) and issued 4,766,219 Class A shares to lenders tied to Amendment No. 14. Long‑term debt (net) rose to $581,844 thousand, and the company ended the quarter with cash of $32,076 thousand. Nine‑month operating cash flow was an outflow of $82,873 thousand.
Management disclosed a significant likelihood of failing to maintain covenant compliance within 12 months absent mitigating actions, and initiated cost measures including a Q4 2025 workforce reduction of approximately 487 employees. As of November 6, 2025, shares outstanding were 16,093,116 Class A and 12,620,884 Class B.
GoHealth (GOCO) reported an insider transaction by its Chief Financial Officer on a Form 4. On 11/01/2025, the CFO had 12,725 shares of Class A common stock withheld at $3.96 per share, coded F, to satisfy tax withholding obligations tied to the vesting of 50,000 restricted stock units granted on November 1, 2024.
Following this transaction, the officer beneficially owns 237,275 shares directly. The filing reflects tax-related share withholding upon RSU vesting rather than an open-market sale.
GoHealth insider tax-withholding sale tied to RSU vesting. Mike Hargis, the company's Chief Operating Officer, reported a sale of 5,545 shares of Class A common stock on 09/12/2025 at a price of $4.98 per share. The filing states these shares were withheld by the company to satisfy tax withholding obligations related to the vesting of 22,222 restricted stock units granted on 09/12/2022. After the withholding, Hargis beneficially owns 324,993 shares directly. The form indicates the transaction was reported by a single reporting person and executed through an attorney-in-fact.
Mark Robert Weinstein, listed at the Chicago address on the form, filed an Initial Statement of Beneficial Ownership (Form 3) reporting his relationship to GoHealth, Inc. (GOCO) as a Director. The event date shown is 08/19/2025. The filing states no securities are beneficially owned and notes the Form was submitted late due to delays obtaining the reporting person’s EDGAR codes. The filing includes Exhibit 24 (Power of Attorney) and is signed on behalf of the reporting person by an attorney-in-fact on 09/02/2025. The filing was made by one reporting person.
Form 3 filed for GoHealth, Inc. (GOCO) reports that Truong Bao Dinh, identified as a Director, had no securities beneficially owned as of the event date
Public Sector Pension Investment Board (PSP) filed an Initial Statement of Beneficial Ownership reporting indirect beneficial ownership of 1,680,526 shares of GoHealth, Inc. (GOCO) Class A common stock. The filing identifies PSP USA, a wholly owned PSP subsidiary, as holding 1,680,444 shares directly and an additional 82 shares through a fund-of-one, which PSP may be deemed to indirectly own. The event requiring the statement is dated 08/06/2025 and the form is signed by Martine Vanasse, MD & Chief Compliance Officer on 08/15/2025. The filer is identified as a Director relationship to the issuer and the filing is an initial Form 3 disclosure.
GoHealth, Inc. issued Class A Common Stock to lenders as part of an amendment to its credit agreement, and two related reporting persons filed a joint Schedule 13D disclosing their holdings. The Public Sector Pension Investment Board (PSP) reports beneficial ownership of 1,680,526 shares (reported as 10.5% of the class). PSP Investments Credit USA LLC reports beneficial ownership of 1,680,444 shares (reported as 10.5% of the class).
The percentage figures are calculated using an outstanding base of 11,222,135 shares as of August 5, 2025, plus 4,766,219 shares issued on August 6, 2025. The shares were issued to lenders, including PSP USA, as consideration and a condition to the lenders’ entry into Amendment No. 14 to the existing credit agreement. The filing states no other transactions in the past 60 days by the reporting persons and discloses no criminal or securities-related judgments for the reporting persons or their scheduled officers.
FAQ
What is the current stock price of Gohealth (GOCO)?
What is the market cap of Gohealth (GOCO)?
